SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

PetMed Express, Inc. Names Sandra Campos as new Chief Executive Officer and President

CG Oncology to Host Virtual Investor Event on Friday, May 3, 2024

Crossject reports audited financial results for 2023

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K

CG Oncology to Unveil Encouraging Results on Cretostimogene in Combination with Pembrolizumab at ASCO 2024

Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference

ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call

OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th

StateHouse Provides an Update on Application for Management Cease Trade Order

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Journal of Craniofacial Surgery Study Proves Planatome Blades Reduce Tissue Damage and Improve Diabetic Wound Healing from Surgical Incisions

EssilorLuxottica: Q1 2024 Revenue - Solid revenue trend in the first quarter

Growth of 28% of 2024 first quarter revenue

StateHouse Appoints Felicia Snyder as Independent Chair of the Board

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

PetMeds® Announces Fiscal 2024 Third Quarter Financial Results and Completion of Financial Restatement

Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024

EssilorLuxottica closes the acquisition of Washin to grow its optical retail presence in Japan

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2024

EssilorLuxottica: First-Quarter 2024 Revenue Conference Call Invitation

Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS

Crossject trading on Euronext to resume as usual on Wednesday April 3

Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Crossject advances in its U.S. Strategy and reports Financial Results for 2023

Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL

CG Oncology to Present Results on Cretostimogene at the AUA 2024 Annual Meeting

2023 Shareholders General Meeting

United Health Products Submits Full FDA PMA Application

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of March 13, 2024

Impressive $3.3M investment in Basic Mental Health Research

Anika Reports Fourth Quarter and Year-End 2023 Financial Results

Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2023 Financial Results

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum

Teknova Reports Fourth Quarter and Full Year 2023 Financial Results

Brain Canada Celebrates Brain Health Awareness Month with Boost your Brain Awareness Campaign

Confluent Appoints Sandy Stojkovski and Brian Yoor to its Board of Directors

EssilorLuxottica: 2023 Universal Registration Document filed

Crossject gender equality score reaches 96/100 in 2024

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Crossject to present at Biotech Showcase on January 9 at 16:30 PT

EssilorLuxottica showcases its smart and hearing aided eyewear innovation with first appearance at CES 2024 in Las Vegas

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

Shares reverse split

Crossject engages Syneos Health for U.S. commercial launch of ZEPIZURE®

OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company

Crossject signs ZEPIZURE® commercialization agreement for northern Europe

CooperCompanies to Present at the J.P. Morgan Healthcare Conference

Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of November 30, 2023

StateHouse Grants Restricted Share Units

CooperCompanies Announces Fourth Quarter and Full Year 2023 Results

Brain Canada, Weizmann Canada and the Weizmann Institute of Science Announce a New International Brain Research Collaboration

Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody

CooperCompanies Appoints Lawrence E. Kurzius to Board of Directors

Biocon Biologics Successfully Completes Integration of Viatris’ Biosimilar Business in 31 Countries in Europe

StateHouse Reports Third Quarter 2023 Financial Results

Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release

Crossject announces initiation of coverage by ODDO BHF